Oncotarget
The cover for issue 22 of Oncotarget features Figure 4, "Myoblasts stimulated by gravity (G) release miRNA-microvesicles inhibiting breast cancer cell growth," by Alessandra, et al.
Panaxynol, a bioactive component of American ginseng, targets macrophages and suppresses colitis in mice |
https://doi.org/10.18632/oncotarget.27592 Anusha Chaparala, Deepak Poudyal, Hossam Tashkandi, Erin E. Witalison, Alexander A. Chumanevich, Jenna L. Hofseth, Ivy Nguyen, Olivia Hardy, Douglas L. Pittman, Michael D. Wyatt, Anthony Windust, Elizabeth A. Murphy, Mitzi Nagarkatti, Prakash Nagarkatti, and Lorne J. Hofseth |
2026-2036 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
HSP90 overexpression potentiates the B-cell receptor and fibroblast growth factor receptor survival signals in chronic lymphocytic leukemia cells |
https://doi.org/10.18632/oncotarget.27409 Hasan Mahmud, Mariana Mendez, Bedabrata Mukhopadhyay, Jennifer Holter-Chakrabarty, and Asish K. Ghosh |
2037-2046 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Carcinogenetic initiation contributed by EpCAM+ cancer cells in orthotopic HCC models of immunocompetent and athymic mice |
https://doi.org/10.18632/oncotarget.27454 Harshul Pandit, Yan Li, Qianqian Zheng, Wei Guo, Youxi Yu, Suping Li, and Robert C.G. Martin |
2047-2060 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Order a Reprint |
Hereditary pancreatitis model by blastocyst complementation in mouse |
https://doi.org/10.18632/oncotarget.27595 Ayumu Asai, Masamitsu Konno, Koichi Kawamoto, Ayako Isotani, Masaki Mori, Hidetoshi Eguchi, Yuichiro Doki, Takahiro Arai, and Hideshi Ishii |
2061-2073 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Efficacy of osimertinib against EGFRvIII+ glioblastoma |
https://doi.org/10.18632/oncotarget.27599 Gustavo Chagoya, Shawn G. Kwatra, Cory W. Nanni, Callie M. Roberts, Samantha M. Phillips, Sarah Nullmeyergh, Samuel P. Gilmore, Ivan Spasojevic, David L. Corcoran, Christopher C. Young, Karla V. Ballman, Rohan Ramakrishna, Darren A. Cross, James M. Markert, Michael Lim, Mark R. Gilbert, Glenn J. Lesser, and Madan M. Kwatra |
2074-2082 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Second line trastuzumab emtansine following horizontal dual blockade in a real-life setting |
https://doi.org/10.18632/oncotarget.27603 Salvatore Del Prete, Liliana Montella, Grazia Arpino, Giuseppe Buono, Carlo Buonerba, Pasquale Dolce, Olga Fiorentino, Maria Aliberti, Antonio Febbraro, Clementina Savastano, Giuseppe Colantuoni, Ferdinando Riccardi, Angela Ruggiero, Sabino De Placido, and Michele Orditura |
2083-2091 |
Abstract | PDF | Full Text | How to cite | Press Release | Podcast | Order a Reprint |
Adoptive cell therapy in combination with checkpoint inhibitors in ovarian cancer |
https://doi.org/10.18632/oncotarget.27604 Anders Handrup Kverneland, Magnus Pedersen, Marie Christine Wulff Westergaard, Morten Nielsen, Troels Holz Borch, Lars Rønn Olsen, Gitte Aasbjerg, Saskia J. Santegoets, Sjoerd H. van der Burg, Katy Milne, Brad H. Nelson, Özcan Met, Marco Donia, and Inge Marie Svane |
2092-2105 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Anticancer effect of physical activity is mediated by modulation of extracellular microRNA in blood |
https://doi.org/10.18632/oncotarget.27609 Alessandra Pulliero, Ming You, Pradeep Chaluvally-Raghavan, Barbara Marengo, Cinzia Domenicotti, Barbara Banelli, Paolo Degan, Luigi Molfetta, Fabio Gianiorio, and Alberto Izzotti |
2106-2119 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Podcast | Order a Reprint |
Review: Organic nanoparticle based active targeting for photodynamic therapy treatment of breast cancer cells |
https://doi.org/10.18632/oncotarget.27596 Hanieh Montaseri, Cherie Ann Kruger, and Heidi Abrahamse |
2120-2136 |
Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release | Order a Reprint |
Hyperprogression to a dual immune blockade followed by subsequent response with cabozantinib in metastatic poor-risk clear cell renal cell carcinoma with NOTCH mutation |
https://doi.org/10.18632/oncotarget.27598 Javier Molina-Cerrillo, Teresa Alonso-Gordoa, Alfredo Carrato, and Enrique Grande |
2137-2140 |
Abstract | PDF | Full Text | How to cite | Press Release | Podcast | Order a Reprint |
Copyright © 2021 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC